SA 16

CAS No. 1919884-11-9

SA 16( SA-16 | SA 16 | SA16 )

Catalog No. M13010 CAS No. 1919884-11-9

A potent, dual PDK1 and Aurora kinase A inhibitor with IC50 of 416 and 35 nM, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SA 16
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, dual PDK1 and Aurora kinase A inhibitor with IC50 of 416 and 35 nM, respectively.
  • Description
    A potent, dual PDK1 and Aurora kinase A inhibitor with IC50 of 416 and 35 nM, respectively; blocks glioblastoma multiforme (GBM) proliferation with no toxicity in normal cells, induces GBM apoptosis and inhibits cell migration; exhibits an increased efficacy against glioma stem cells (GSCs), inducing their differentiation and apoptosis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SA-16 | SA 16 | SA16
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Aurora Kinase
  • Recptor
    Aurora Kinase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1919884-11-9
  • Formula Weight
    606.59
  • Molecular Formula
    C33H24F2N6O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(C1=CC=CN(CC2=CC=C(F)C(F)=C2)C1=O)N[C@H](C3=CC=CC=C3)C(NC4=CC5=C(NC(/C5=C\C6=CN=CN6)=O)C=C4)=O
  • Chemical Name
    (R,Z)-N-(2-((3-((1H-imidazol-5-yl)methylene)-2-oxoindolin-5-yl)amino)-2-oxo-1-phenylethyl)-1-(3,4-difluorobenzyl)-2-oxo-1,2-dihydropyridine-3-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Daniele S, et al. ACS Chem Neurosci. 2017 Jan 18;8(1):100-114. 2. Nagashima K, et al. J Biol Chem. 2011 Feb 25;286(8):6433-48.
molnova catalog
related products
  • Tozasertib

    Tozasertib (MK-0457, VX-680) is a highly potent, selective and reversible Aurora kinase inhibitor with Ki of 0.6, 18 and 4.6 nM for Aurora A, B and C, respectively.

  • BPR1K653

    BPR1K653 is a novel potent Aurora kinase inhibitor that inhibits Aurora-A and Aurora-B with IC50 of 24 nM and 45 nM, respectively.

  • AKI-603

    A novel small molecule Aurora A kinase inhibitor with IC50 of 12.3 nM, also inhibits Aurora B kinase activity to a less extent.